AnalystsInsight

Pamela Zuluaga (Morgan Stanley): Analyst Track Record and Price‑Target Accuracy

How often Pamela Zuluaga’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 2 ratings, compared with the average Wall Street analyst.

Published Updated 3 min readHow we research

What changed since Oct 12

Exent re-checks this page every day. Ratings appear 30 days after they are published; live calls are in Gems.

#355 rank (was #399)4.9★ rating (was 4.8★)

Key takeaways

  • Pamela Zuluaga ranks #343 of 1,000 analysts in Exent’s scoring (4.9★).
  • — of price targets were reached over 7 years, versus 52.4% for the average analyst.
  • Median time to reach a target: — days; 100.0% of calls were up 12 months later.
  • Most‑covered stocks: BIT-UCG, BIT-ISP, BME-SAN, LON-0RJN.
  • Free on Exent: Pamela Zuluaga’s full record, with ratings 3 days after publication.

Pamela Zuluaga’s track record at a glance

Pamela Zuluaga of Morgan Stanley ranks #343 of the 1,000 analysts Exent scores, with a 4.9★ rating and a focus on financials. Over a 7‑year lookback, — of Pamela’s price targets were reached, the 52.4% average across all analysts.

MetricPamela ZuluagaAll analysts
Price‑target hit rate—52.4%
Median days to hit target—91 days
Calls up after 12 months100.0%64.0%
Median 12‑month return of calls+11.5%+13.4%
Hit rate, last 2 years——
Average worst drop after a call−32.4%—
Ratings in the sample2—
Stocks covered10—

The full records of Exent’s top 90 analysts and the top 50 of each sector, and the stocks where several of them agree right now, are members‑only in Exent Gems.

How fast price targets were reached

Time to reach the targetPamela Zuluaga
Under 30 days—
30–90 days—
90–180 days—
Over 180 days—

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks Pamela Zuluaga covers most

StockRatings in the sample
BIT-UCG62
BIT-ISP50
BME-SAN36
LON-0RJN32
BME-BBVA30
BIT-BAMI20
BIT-MB16
BME-CABK14

In the past year Pamela’s ratings were 0% Buy, 100% Hold and 0% Sell.

Pamela Zuluaga’s latest ratings

DateStockActionRatingPrice target
Nov 24, 2025LON-0RJNMaintainedHold$0.82
Nov 24, 2025LON-0RJNMaintained: HoldHold$0.82
Oct 10, 2025LON-0RJNMaintained: HoldHold$0.83
Oct 10, 2025LON-0RJNMaintainedHold$0.83
Sep 2, 2025BIT-BAMIMaintained: HoldHold$13.30
Sep 2, 2025LON-0RJNMaintained: HoldHold$0.81
Sep 2, 2025LON-0RJNMaintainedHold$0.81
Sep 2, 2025BIT-BAMIMaintainedHold$13.30
Aug 7, 2025BIT-BAMIMaintainedHold$12.20
Aug 7, 2025BIT-BAMIMaintained: HoldHold$12.20
Aug 4, 2025LON-0RJNMaintained: HoldHold$0.74
Aug 4, 2025LON-0RJNMaintainedHold$0.74
  • Nov 24, 2025
    Stock
    LON-0RJN
    Action
    Maintained
    Rating
    Hold
    Price target
    $0.82
  • Nov 24, 2025
    Stock
    LON-0RJN
    Action
    Maintained: Hold
    Rating
    Hold
    Price target
    $0.82
  • Oct 10, 2025
    Stock
    LON-0RJN
    Action
    Maintained: Hold
    Rating
    Hold
    Price target
    $0.83
  • Oct 10, 2025
    Stock
    LON-0RJN
    Action
    Maintained
    Rating
    Hold
    Price target
    $0.83
  • Sep 2, 2025
    Stock
    BIT-BAMI
    Action
    Maintained: Hold
    Rating
    Hold
    Price target
    $13.30
  • Sep 2, 2025
    Stock
    LON-0RJN
    Action
    Maintained: Hold
    Rating
    Hold
    Price target
    $0.81
  • Sep 2, 2025
    Stock
    LON-0RJN
    Action
    Maintained
    Rating
    Hold
    Price target
    $0.81
  • Sep 2, 2025
    Stock
    BIT-BAMI
    Action
    Maintained
    Rating
    Hold
    Price target
    $13.30
  • Aug 7, 2025
    Stock
    BIT-BAMI
    Action
    Maintained
    Rating
    Hold
    Price target
    $12.20
  • Aug 7, 2025
    Stock
    BIT-BAMI
    Action
    Maintained: Hold
    Rating
    Hold
    Price target
    $12.20
  • Aug 4, 2025
    Stock
    LON-0RJN
    Action
    Maintained: Hold
    Rating
    Hold
    Price target
    $0.74
  • Aug 4, 2025
    Stock
    LON-0RJN
    Action
    Maintained
    Rating
    Hold
    Price target
    $0.74

Pamela’s ratings are free on Exent 3 days after publication. Exent Gems has them the same day, with the calls of the top‑ranked analysts and the stocks where several of them agree.

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Jun 24, 2026; ranking updated Oct 20, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

  1. Exent Gems shows Pamela Zuluaga’s live ratings and those of the top‑ranked analysts, without the 30‑day delay used on this page.
  2. Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
  3. Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring Pamela Zuluaga ranks #343 of 1,000 with a 4.9★ rating. — of price targets were reached over a 7-year lookback (all analysts: 52.4%), and 100.0% of calls were up 12 months later. Past accuracy does not guarantee future accuracy.

Pamela Zuluaga’s success rate is 85.7% by the ranking source and — by Exent’s price-target hit-rate backtest, with a median of — days to reach a target.

Pamela Zuluaga (Morgan Stanley) covers 10 stocks, mostly in financials. The most frequently rated are BIT-UCG, BIT-ISP, BME-SAN, LON-0RJN, BME-BBVA.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.